IRIS International, Inc. - Product Pipeline Analysis, 2014 Update

Date: May 14, 2014
Pages: 30
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IC9EF3E4CC6EN
Leaflet:

Download PDF Leaflet

IRIS International, Inc. - Product Pipeline Analysis, 2014 Update
Summary

IRIS International, Inc. (Iris) designs, develops, manufactures and markets in-vitro diagnostic systems that analyze particles and living cell forms and structures of a variety of body fluids. The company carries out its business through three divisions, namely, Iris Diagnostics, Iris Sample Processing and Iris Personalized Medicine. Its major products include in-vitro diagnostic urinalysis systems, integrated urinalysis software, sample collection systems, sample processing systems, benchtop centrifuges, small instruments and supplies. It also develops and commercialize NADiA ultra-sensitive nucleic acid detection immunoassay platform, with applications in oncology and infectious diseases. The company exports its products to more than 50 countries. Iris is a subsidiary of Danaher Corporation and is headquartered in California, the US.

The company seeks to maintain a leading position in automated in vitro diagnostics for urinalysis and sample processing at the same time becoming a global leader in hematology and molecular diagnostics by offering efficient products and solutions.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company IRIS International, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
IRIS International, Inc. Company Snapshot
IRIS International, Inc. Company Overview
Key Information
IRIS International, Inc. Pipeline Products and Clinical Trials Overview
IRIS International, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
IRIS International, Inc. - Major Products and Services
IRIS International, Inc. Pipeline Products by Development Stage
IRIS International, Inc. Pipeline Products Overview
3GEMS HEMATOLOGY ANALYZER
3GEMS HEMATOLOGY ANALYZER PRODUCT OVERVIEW
3GEMS NEXT GENERATION URINALYSIS PLATFORM
3GEMS NEXT GENERATION URINALYSIS PLATFORM PRODUCT OVERVIEW
NADIA CEC - Breast Cancer
NADIA CEC - Breast Cancer Product Overview
NADIA CEC - Prostate Cancer
NADIA CEC - Prostate Cancer Product Overview
NADiA HIV
NADiA HIV Product Overview
IRIS International, Inc. - Key Competitors
IRIS International, Inc. - Key Employees
IRIS International, Inc. - Key Employee Biographies
IRIS International, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
IRIS International, Inc., Recent Developments
Sep 20, 2012: Iris International To Present NADiA ProsVue At Two Meetings In Washington DC
Aug 16, 2012: IRIS International Selects ThingWorx For Next-Generation Remote Service And Support Of Medical Devices
Jul 31, 2012: IRIS International Reports Revenue Of $30.9m In Q2 2012
Jun 06, 2012: IRIS International Announces Clinical Data Presentation Of NADiA ProsVue Benefits At 5th International Symposium On Focal Therapy And Imaging In Prostate And Kidney Cancer
May 21, 2012: Iris International Unveils NADiA ProsVue At AUA Annual Meeting
May 02, 2012: IRIS International Reports Revenue Of $29.9m In Q1 2012
Mar 19, 2012: IRIS International Commences Commercial Shipment Of ThermoBrite Elite
Mar 01, 2012: IRIS International Reports Revenue Of $118.3m In 2011
Feb 21, 2012: IRIS Launches NADiA ProsVue Prognostic Cancer Test In US
Nov 17, 2011: IRIS Introduces ThermoBrite Elite AMP 2011 Annual Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

IRIS International, Inc., Key Facts
IRIS International, Inc. Pipeline Products and Clinical Trials Overview
IRIS International, Inc. Pipeline Products by Equipment Type
IRIS International, Inc. Pipeline Products by Indication
IRIS International, Inc., Key Facts
IRIS International, Inc., Major Products and Services
IRIS International, Inc. Number of Pipeline Products by Development Stage
IRIS International, Inc. Pipeline Products Summary by Development Stage

3GEMS HEMATOLOGY ANALYZER - PRODUCT STATUS


3GEMS HEMATOLOGY ANALYZER - PRODUCT DESCRIPTION


3GEMS NEXT GENERATION URINALYSIS PLATFORM - PRODUCT STATUS


3GEMS NEXT GENERATION URINALYSIS PLATFORM - PRODUCT DESCRIPTION

NADIA CEC - Breast Cancer - Product Status
NADIA CEC - Breast Cancer - Product Description
NADIA CEC - Prostate Cancer - Product Status
NADIA CEC - Prostate Cancer - Product Description
NADiA HIV - Product Status
NADiA HIV - Product Description
IRIS International, Inc., Key Employees
IRIS International, Inc., Key Employee Biographies
IRIS International, Inc., Other Locations
IRIS International, Inc., Subsidiaries

LIST OF FIGURES

IRIS International, Inc. Pipeline Products by Equipment Type
IRIS International, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

IRIS International, Inc. - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: